3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
5
Unknown
4
Not yet recruiting
4
Completed
2
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
2679
Pancreatic Neoplasms
1470
Colonic Neoplasms
1159
Carcinoma, Hepatocellular
1142
Stomach Neoplasms
1129
Rectal Neoplasms
980
Esophageal Neoplasms
728
Neoplasms
559
Liver Neoplasms
533
Breast Neoplasms
473
Neoplasm Metastasis
373
Lung Neoplasms
325
Carcinoma, Non-Small-Cell Lung
292
Gastrointestinal Neoplasms
277
Ovarian Neoplasms
258
Prostatic Neoplasms
229
Cholangiocarcinoma
221
Head and Neck Neoplasms
180
Gastrointestinal Stromal Tumors
176
Melanoma
165
Esophageal Squamous Cell Carcinoma
164
Barrett Esophagus
156
Uterine Cervical Neoplasms
151
Biliary Tract Neoplasms
149
Adenocarcinoma Of Esophagus
148
Gallbladder Neoplasms
136
Carcinoma, Renal Cell
134
Urinary Bladder Neoplasms
132
Sarcoma
131
Anus Neoplasms
124
Interventions
Gemcitabine
2
tremelimumab
1
pamrevlumab
1
folfirinox
1
durvalumab
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Pancreatic Cancer Non-resectable
×
Gastrointestinal
×
Clear all
NCT03941093
2024-11-05
LAPIS
Kyntra Bio
Phase 3
Completed
284 enrolled
14 charts
NCT04156087
2024-09-19
MIMIPAC
University Hospital, Gasthuisberg
Phase 2
Completed
12 enrolled